155 research outputs found

    UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review

    Get PDF
    BACKGROUND: Broad-band UVA, long-wave UVA1 and PUVA treatment have been described as an alternative/adjunct therapeutic option in a number of inflammatory and malignant skin diseases. Nevertheless, controlled studies investigating the efficacy of UVA irradiation in connective tissue diseases and related disorders are rare. METHODS: Searching the PubMed database the current article systematically reviews established and innovative therapeutic approaches of broad-band UVA irradiation, UVA1 phototherapy and PUVA photochemotherapy in a variety of different connective tissue disorders. RESULTS: Potential pathways include immunomodulation of inflammation, induction of collagenases and initiation of apoptosis. Even though holding the risk of carcinogenesis, photoaging or UV-induced exacerbation, UVA phototherapy seems to exhibit a tolerable risk/benefit ratio at least in systemic sclerosis, localized scleroderma, extragenital lichen sclerosus et atrophicus, sclerodermoid graft-versus-host disease, lupus erythematosus and a number of sclerotic rarities. CONCLUSIONS: Based on the data retrieved from the literature, therapeutic UVA exposure seems to be effective in connective tissue diseases and related disorders. However, more controlled investigations are needed in order to establish a clear-cut catalogue of indications

    Komplikationsmangament in der thorakalen Wirbelsäulenchirurgie - Case report

    No full text

    Evidence for an A2_2 adenosine receptor in guinea pig lung

    No full text
    Adenosine receptors in guinea pig lung were characterized by measurement of cyclic AMP formation and radioligand binding. 5'-N-Ethylcarboxamidoadenosine (NECA) increased cyclic AMP Ievels in lung slices about 4-fold over basal values with an EC50_{50} of 0.32 ÎĽ\mumol/l. N6^6 - R-(- )-Phenylisopropyladenosine (R-PIA) was 5-fold less potent than NECA. 5'-N-Methylcarboxamidoadenosine (MECA) and 2-chloroadenosine had EC50_{50}-values of 0.29 and 2.6 ÎĽ\mumol/l, whereas adenosine and inosine had no effect. The adenosine receptors in guinea pig Iung can therefore be classified as A2_2 receptors. Several xanthine derivatives antagonized the NECA-induced increase in cyclic AMP levels. 1,3-Diethyl-8-phenylxanthine (DPX; Ki_i 0.14 ÎĽ\mumol/l) was the most potent analogue, followed by 8-phenyltheophylline (Ki_i 0.55 ÎĽ\mumol/l), 3-isobutyl-1-methylxanthine (IBMX; Ki_i 2.9 ÎĽ\mumol/l) and theophylline (Ki_i 8.1 ÎĽ\mumol/l). In contrast, enprofylline (1 mmol/1) enhanced basal and NECA-stimulated cyclic AMP formation. In addition, we attempted to characterize these receptors in binding studies with [3^3H]NECA. The KD_D for [3^3H] NECA was 0.25 ÎĽ\mumol/l and the maximal number of binding sites was 12 pmol/mg protein. In competition experiments MECA (Ki_i 0.14 ÎĽ\mumol/l) was the most potent inhibitor of [3^3H] NECA binding, followed by NECA (Ki_i 0.19 ÎĽ\mumol/l) and 2-chloroadenosine (Ki_i 1.4 ÎĽ\mumol/l). These results correlate well with the EC50_{50}- values for cyclic AMP formation in lung slices. However, the Ki_i-values of R-PIA and theophylline were 240 and 270 ÎĽ\mumol/l, and DPX and 8-phenyltheophylline did not compete for [3^3H]NECA binding sites. Therefore, a complete characterization of A2_2 adenosine receptors by [3^3H] NECA binding was not achieved. In conclusion, our results show the presence of adenylate cyclase-coupled A2_2 adenosiile receptors in lung tissue which are antagonized by several xanthines

    Buchbesprechungen

    No full text

    Analysis of T cell activation pathways in patients with liver cirrhosis, impaired delayed hypersensitivity and other T cell-dependent functions

    No full text
    Patients with cirrhosis of the liver frequently demonstrate anergy in intracutaneous tests and fail to respond to vaccination, suggesting impaired delayed hypersensitivity and other T cell-dependent functions in vivo. T cell activation through the coordinated interaction of different cells of the immune system (B cell, antigen-presenting cells (APC)) is an important step in the induction of cellular and humoral immune responses. Impaired T cell-dependent functions in patients with liver cirrhosis may thus be explained by defective T cell activation. We prospectively investigated T cell activation pathways in 12 patients (nine males, three females) with alcoholic liver cirrhosis (seven Child Pugh stage A and B (CP A+B), five Child Pugh stage C (CP C)) and five healthy controls and compared the in vitro results of T cell activation with data obtained in vivo, e.g. intracutaneous tests and vaccination against hepatitis B surface antigen (HBs-Ag). Five out of eight patients who completed vaccination against hepatitis B virus infection were non-responders; one of the three responders had a non-protective anti-HBs titre. Moreover, three of five patients with alcoholic liver cirrhosis CP A+B, and two out of three with CP C were anergic in intracutaneous tests to a set of diverse antigens. All parameters of T cell activation were normal, including proliferation mediated by CD2, CD3–T cell receptor (TCR) complex, and CD28; acquisition of responsiveness to exogenous IL-2 and IL-4; activation of proteinkinase C (PKC) by phorbol ester and calcium influx by addition of ionomycin. The ability of monocytes to deliver costimulatory signals was preserved in patients with alcoholic cirrhosis. In addition, serum of patients with alcoholic liver disease did not inhibit T cell proliferation. We conclude that, although in patients with alcoholic liver cirrhosis T cell-dependent functions are impaired in vivo, T cell activation pathways are not responsible for the observed immune defect

    Buchbesprechungen

    No full text
    • …
    corecore